Stocks and Investing
Stocks and Investing
Thu, March 7, 2024
[ Thu, Mar 07th 2024
] - WOPRAI
[ Thu, Mar 07th 2024
] - WOPRAI
[ Thu, Mar 07th 2024
] - WOPRAI
[ Thu, Mar 07th 2024
] - WOPRAI
[ Thu, Mar 07th 2024
] - WOPRAI
[ Thu, Mar 07th 2024
] - WOPRAI
Wed, March 6, 2024
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
[ Wed, Mar 06th 2024
] - WOPRAI
Rachel Vatnsdal Maintained (AKYA) at Buy with Decreased Target to $10 on, Mar 6th, 2024
Rachel Vatnsdal of JP Morgan, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $12 to $10 on, Mar 6th, 2024.
Rachel has made no other calls on AKYA in the last 4 months.
There are 5 other peers that have a rating on AKYA. Out of the 5 peers that are also analyzing AKYA, 1 agrees with Rachel's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Subbu Nambi of "Guggenheim" Initiated at Hold on, Thursday, December 14th, 2023
These are the ratings of the 4 analyists that currently disagree with Rachel
- John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $7.5 on, Tuesday, March 5th, 2024
- Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $10 on, Tuesday, March 5th, 2024
- David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $8 on, Monday, November 13th, 2023
- Mason Carrico of "Stephens & Co." Maintained at Buy with Decreased Target to $9 on, Monday, November 13th, 2023
Contributing Sources